Research Breakthrough: Scientists Test Nanorobots to Treat Brain Aneurysms
In an exciting development, scientists test nanorobots to treat brain aneurysms, highlighting the potential of nanotechnology in medical innovation. A recent study indicates that these minuscule machines, measuring just 295 nanometers, could deliver clotting drugs directly to aneurysms, thereby aiding in stroke prevention.
How the Nanorobots Work
The research reveals that these nanobots consist of a magnetic core, a clotting agent known as thrombin, and a heat-sensitive coating. By guiding the nanobots using a magnetic field, surgeons can navigate them to the aneurysm site, where heated conditions release the drug, forming stable clots that prevent further blood flow into the aneurysm.
Successful Testing in Rabbits
So far, testing has been conducted on rabbits with induced aneurysms. The results are promising; the study indicated that the clots formed successfully, effectively blocking the aneurysm while keeping the rabbits healthy during follow-up checks.
Next Steps in the Research
The research team aims to progress to larger animal trials that better represent human physiology. Enhancements to the magnetic control mechanisms are also planned for improved targeting of aneurysms situated deeper within the brain.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.